Vaccine Overview
Ganirelix Acetate for Injection 0.25 mg
Ganirelix acetate is a GnRH antagonist used during fertility treatments to inhibit premature luteinizing hormone (LH) surges, thereby enhancing outcomes in controlled ovarian hyperstimulation cycles. Administered via subcutaneous injection, it is usually started after several days of follicle-stimulating hormone (FSH) therapy and continued until the day of ovulation trigger. It ensures proper timing for egg retrieval in IVF. Side effects may include abdominal discomfort, injection site reactions, and headache. It is used under the direction of fertility specialists to improve reproductive success rates.
Drug Class: Pharma Products
Indication: Suppresses LH surge during ART procedures like IVF

PREVENTS
Vaccine Details
Applied To
Adults
Recommended Time
Daily injections, usually Days 5–9 of cycle
Administration
Route: Subcutaneous Injection
Site: Abdomen (alternating injection sites)
Disease
IVF Cycle (Premature LH Surge)
Manufacturer
Serum Intitute Of India
Age
- Women (20–45 yrs)
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025